Pooja Middha Kapoor

14PUBLICATIONS
220CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 28, 2025
Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events.

Pooja Middha, Rohit Thummalapalli, Zoe Quandt

|Nov 22, 2024
Unraveling the genetic landscape of susceptibility to multiple primary cancers.

Pooja Middha, Linda Kachuri, Jovia L Nierenberg

|Jul 01, 2024
Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events.

Pooja Middha, Rohit Thummalapalli, Zoe Quandt

|Mar 27, 2024
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis.

Pooja Middha, Rohit Thummalapalli, Michael J Betti

|May 15, 2023
Development and testing of a polygenic risk score for breast cancer aggressiveness.

Yiwey Shieh, Jacquelyn Roger, Christina Yau

|Jun 20, 2022
Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies.

Audrey Y Jung, Thomas U Ahearn, Sabine Behrens

Pageof 3

Frequent Collaborators

9 joint publications

Paul D P Pharoah

7 joint publications

Pascal Guénel

7 joint publications

Anna Jakubowska

7 joint publications

Roger L Milne